HomeHIK • LON
Hikma Pharmaceuticals Plc
GBX 1,893.00
Mar 19, 10:06:46 AM UTC · GBX · LON · Disclaimer
StockGB listed security
Previous close
GBX 1,883.00
Day range
GBX 1,881.00 - GBX 1,895.50
Year range
GBX 1,614.50 - GBX 2,222.00
Market cap
4.20B GBP
Avg Volume
508.84K
P/E ratio
28.22
Dividend yield
3.02%
Primary exchange
LON
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
724.00M11.04%
Operating expense
180.00M3.15%
Net income
29.50M293.33%
Net profit margin
4.07253.91%
Earnings per share
EBITDA
175.00M-8.62%
Effective tax rate
22.78%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
205.00M-29.79%
Total assets
4.68B4.67%
Total liabilities
2.47B6.37%
Total equity
2.21B
Shares outstanding
220.72M
Price to book
1.89
Return on assets
8.41%
Return on capital
11.58%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
29.50M293.33%
Cash from operations
193.00M6.93%
Cash from investing
-107.00M-111.88%
Cash from financing
-119.50M31.52%
Net change in cash
-33.50M33.66%
Free cash flow
71.06M-17.79%
About
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Founded
1978
Website
Employees
9,100
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu